GENB (Generate Biomedicines) EPS (Diluted): $ (TTM As of Dec. 2025)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines EPS (Diluted)?

Generate Biomedicines GENB +2.18% 6 EPS (Diluted) is $ as of Dec. 2025. GuruFocus rates GENB with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Generate Biomedicines's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was $-2.18.

Generate Biomedicines's EPS (Basic) for the six months ended in Dec. 2025 was $-2.18.

Generate Biomedicines's EPS without NRI for the six months ended in Dec. 2025 was $-2.18.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Generate Biomedicines  (NAS:GENB) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Generate Biomedicines EPS (Diluted) Related Terms

Generate Biomedicines EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines EPS (Diluted) Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
EPS (Diluted)
-2.09 -2.18

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
EPS (Diluted) -2.09 -2.18

GENB vs PVLA, SLBT, NKTR: EPS (Diluted) Comparison

For the Biotechnology subindustry, Generate Biomedicines's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Generate Biomedicines PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Generate Biomedicines's PE Ratio distribution charts can be found below:

* The bar in red indicates where Generate Biomedicines's PE Ratio falls into.


GENB
6GF Score
Generate Biomedicines Inc GENB
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Generate Biomedicines's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-203.154-46.369)/102.308
=-2.44

Generate Biomedicines's Diluted EPS for the quarter that ended in Dec. 2025 is calculated as

Diluted EPS (Q: Dec. 2025 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-203.154-46.369)/102.308
=-2.44

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of $ mean?
Generate Biomedicines (GENB) has a EPS (Diluted) of $ as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Generate Biomedicines and its competitors.
Is Generate Biomedicines' EPS (Diluted) too high?
Generate Biomedicines' current EPS (Diluted) is $. Overall, Generate Biomedicines has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Generate Biomedicines' EPS (Diluted) compare to PVLA and SLBT?
Generate Biomedicines' EPS (Diluted) of $ can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Biotechnology company?
A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Generate Biomedicines and its competitors. Generate Biomedicines's current EPS (Diluted) is $. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generate Biomedicines stock overvalued right now?
Generate Biomedicines (GENB) has a current EPS (Diluted) of $. The current EPS (Diluted) is $. Generate Biomedicines' overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Generate Biomedicines (GENB), the current EPS (Diluted) is $ as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price